Bahroo Laxman, DO, FAAN, FANA

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Acadia
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Amneal
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Supernus
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Neurocrine
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Revance
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Teva
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Abbvie
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Acadia
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Amneal
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Ipsen
    Topic:
    Spasticity
    Date added:
    09/11/2026
    Date updated:
    09/11/2026

Pages

Return to Spasticity and Movement Disorders IMPACT Initiative (IMproving Patient Assessment and Chemodenervation Treatment